Results 21 to 30 of about 57,071 (293)

Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation [PDF]

, 2010
End-stage liver disease caused by chronic hepatitis C virus (HCV) infection is a leading cause for liver transplantation (LT). Due to viral evasion from host immune responses and the absence of preventive antiviral strategies, reinfection of the graft is
Pessaux, Patrick, Doffoel, Michel, Leroux-Roels, G., Stoll-Keller, Françoise, Michel Doffoël, Patel, Arvind H, Samira Fafi-Kremer, Fofana, I., Soulier, E., Patric Carolla, Fafi-Kremer, S., Doffoel, M., Stoll-Keller, F., Cosset, F.-L., Meuleman, Philip, Fafi-Kremer, Samira, Eric Soulier, Philip Meuleman, Isabel Fofana, Wolf, P., Soulier, Eric, Cosset, François-Loic, François-Loïc Cosset, Leroux-Roels, Geert, Wolf, Philippe, Françoise Stoll-Keller, Philippe Wolf, Carolla, Patric, Pessaux, P., Meuleman, P., Baumert, Thomas F, Patel, A.H., Fofana, Isabel, Patrick Pessaux, Thomas F. Baumert, Arvind H. Patel, Geert Leroux-Roels, Carolla, P., Baumert, T.F.   +38 more
core   +1 more source

Leveraging corona virus disease 2019 vaccination to promote hepatitis C screening

Hepatology Communications, EarlyView., 2022
Abstract Health care initiatives, such as hepatitis C virus (HCV) screening, have been greatly overshadowed by the corona virus disease 2019 (COVID‐19) pandemic. However, COVID‐19 vaccination programs also provide an opportunity to engage with a high volume of people in a health care setting.
Aaron Vanderhoff, David Smookler, Mia J. Biondi, Scott Enman, Tintin Fuliang, Sana Mahmood, Agustina Crespi, Maria Marquez, Rafique Van Uum, Lucy You, Brett Wolfson‐Stofko, Renee Logan, Erin LeDrew, Hemant Shah, Harry Janssen, Camelia Capraru, Elisa Venier, Jordan J. Feld   +17 more
wiley   +1 more source

Post-Vaccination and Post-Infection Immunity to the Hepatitis B Virus and Circulation of Immune-Escape Variants in the Russian Federation 20 Years after the Start of Mass Vaccination

Vaccines, 2023
A neonatal vaccination against the Hepatitis B virus (HBV) infection was initiated in Russia 20 years ago, with catch-up immunization for adolescents and adults under the age of 60 years launched in 2006.
Fedor A. Asadi Mobarkhan, Victor A. Manuylov, Anastasia A. Karlsen, Vera S. Kichatova, Ilya A. Potemkin, Maria A. Lopatukhina, Olga V. Isaeva, Eugeniy V. Mullin, Elena P. Mazunina, Evgeniia N. Bykonia, Denis A. Kleymenov, Liubov I. Popova, Vladimir A. Gushchin, Artem P. Tkachuk, Anna A. Saryglar, Irina E. Kravchenko, Snezhana S. Sleptsova, Victor V. Romanenko, Anna V. Kuznetsova, Sergey A. Solonin, Tatyana A. Semenenko, Mikhail I. Mikhailov, Karen K. Kyuregyan   +22 more
doaj   +1 more source

Association of early age at establishment of chronic hepatitis B infection with persistent viral replication, liver cirrhosis and hepatocellular carcinoma: a systematic review. [PDF]

, 2013
Age at infection with hepatitis B virus (HBV) is a known risk factor for chronic HBV infection. However, in addition, there is some evidence that early age at infection further increases the risk of primary liver cancer beyond its association with ...
Bottomley, Christian, Andrew J Hall, Hong-Jing Yan, Tsuchiya Naho, Hall, Andrew, Andrew J. Hall (78002), Shimakawa Yusuke, Yan, Hong-Jing, Yusuke Shimakawa, Christian Bottomley, Hall Andrew J., Hall, Andrew J, Yan Hong-Jing, Shimakawa, Yusuke, Tsuchiya, Naho, Naho Tsuchiya, Bottomley Christian, Andrew J. Hall, Yusuke Shimakawa (435296), Hong-Jing Yan (435297), Naho Tsuchiya (211103), Christian Bottomley (144483)   +21 more
core   +1 more source

PECULIARITIES OF TREATMENT AND PREVENTION OF INFECTION CAUSED BY HEPATITIS C VIRUS. Review

Медична наука України, 2022
Relevance. The goal of the WHO Global Strategy on Hepatitis Agents, in particular hepatitis C virus, is to identify infected people early for treatment and prevention of chronic infection.
T.L. Hrydina
doaj   +1 more source

Scaling up hepatitis B vaccination with the support of GAVI in China : lessons learned for introduction of new vaccines and for the future of hepatitis B control [PDF]

, 2013
Background: Hepatitis B virus (HBV) infection is a leading cause of illness and death in China. In 1992, 60% of the population had a history of HBV infection and 9.8% were chronically infected with HBV.
Fuqiang, Cui
core   +1 more source

Community screening for hepatitis C virus infection in a low-prevalence population

BMC Public Health, 2019
Background Age cohort screening for hepatitis C virus (HCV) might be an effective strategy if the majority of undiagnosed cases are concentrated in a particular age group.
Karen K. Kyuregyan, Elena Yu. Malinnikova, Natalia V. Soboleva, Olga V. Isaeva, Anastasia A. Karlsen, Vera S. Kichatova, Ilya A. Potemkin, Elena V. Schibrik, Olga A. Gadjieva, Boris A. Bashiryan, Natalya N. Lebedeva, Igor L. Serkov, Anna Yankina, Claudio Galli, Mikhail I. Mikhailov   +14 more
doaj   +1 more source

Vaccines for neonatal viral infections: Hepatitis B vaccine

Expert Review of Vaccines, 2004
In many parts of the world, intervention in the neonatal period is required for prevention of hepatitis B virus infection and its consequences.
F T, Cutts, A J, Hall
openaire   +2 more sources

Molecular Insights into the Development and Efficacy of Hepatitis Virus Vaccines [PDF]

Afro-Egyptian Journal of Infectious and Endemic Diseases
Viral hepatitis remains a major public health challenge globally, especially hepatitis B and C. This puts millions of people at risk of various forms of chronic liver diseases, such as liver cirrhosis, hepatocellular carcinoma, liver failure, etc ...
Ridwanullah Abdullateef, Abdulmujeeb Opatola, Daniel Esanju, Saviour Usin   +3 more
doaj   +1 more source

The Functions of Hepatitis B Virus Encoding Proteins: Viral Persistence and Liver Pathogenesis

Frontiers in Immunology, 2021
About 250 million people worldwide are chronically infected with Hepatitis B virus (HBV), contributing to a large burden on public health. Despite the existence of vaccines and antiviral drugs to prevent infection and suppress viral replication ...
Fenglin Zhao, Fenglin Zhao, Xiaoyu Xie, Xiaoyu Xie, Xiaoyu Xie, Xu Tan, Xu Tan, Hongli Yu, Hongli Yu, Miaomiao Tian, Miaomiao Tian, Huanran Lv, Huanran Lv, Chengyong Qin, Chengyong Qin, Chengyong Qin, Jianni Qi, Jianni Qi, Jianni Qi, Qiang Zhu, Qiang Zhu, Qiang Zhu, Qiang Zhu   +22 more
doaj   +1 more source